Loading…
Speciality Medicines (BSE 544738)₹155.00+4.06%Pharmaceuticals
At the end of the Mar 2026 quarter, Speciality Medicines' shareholders were: promoters 43.44%, FIIs 0.24%, public 56.32%. 0.00% of promoter shares were pledged. It had 756 shareholders.
As of · Company filings (shareholding pattern)
| Mar 2026 | |
|---|---|
| Promoters | 43.44% |
| FIIs | 0.24% |
| Public | 56.32% |
| Promoter shares pledged | 0.00% |
| Number of shareholders | 756 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Parthkumar Babulal Goyani | Promoter | 21.09% | — |
| Sumit Babubhai Goyani | Promoter | 20.64% | — |
| Aparna Samir Thakker | Public | 7.30% | — |
| Jignesh Rajendra Desai | Public | 5.46% | — |
| Yash Hitesh Patel | Public | 2.30% | — |
| Aikyam Capital Private Limited | Public | 1.72% | — |
| Naitik Ashwin Vyas | Public | 1.35% | — |
| Babubhai Lavjibhai Goyani | Promoter | 0.63% | — |
| Bhavika Sumitbhai Goyani | Promoter | 0.46% | — |
| Hansaben Babubhai Goyani | Promoter | 0.40% | — |
| Babubhai Lavjibhai Goyani Huf | Promoter | 0.17% | — |
Promoters held 43.44% of Speciality Medicines at the end of the Mar 2026 quarter.
In the Mar 2026 quarter, foreign institutional investors (FIIs) held 0.24% and domestic institutions (DIIs) held no reported stake.
No. The Mar 2026 filing shows no pledged promoter shares.
Speciality Medicines had 756 shareholders at the end of the Mar 2026 quarter.
Aparna Samir Thakker (Public) held 7.30% at the end of the Mar 2026 quarter, the largest named holding outside the promoter group.